Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-2-16
|
pubmed:abstractText |
The bcl-2 proto-oncogene, which inhibits programmed cell death (apoptosis), has recently been found to be cyclically expressed in human endometrium. In order to investigate its role in endometrial hyperplasia and neoplasia, bcl-2 expression was studied in 25 cases of endometrial carcinoma and 20 cases of endometrial hyperplasia (eight simple, two complex, and ten atypical hyperplasias). Uniform intense cytoplasmic bcl-2 expression was found in all cases of non-atypical hyperplasia, and less strong positivity in eight out of ten cases of atypical hyperplasia. In well-differentiated carcinomas, nine out of ten showed weak to moderate bcl-2 expression, whereas six out of seven poorly differentiated carcinomas were bcl-2-negative. Moderately differentiated tumours were an intermediate group, with six out of eight being positive. Widespread localization of bcl-2 protein to the chromosomes of dividing cells was also demonstrated, regardless of cytoplasmic bcl-2 expression, with rare staining of interphase nuclei. Our findings suggest a role for bcl-2 in the natural history of endometrial neoplasia and studies are needed to determine its usefulness as a prognostic marker. The finding of bcl-2 localization to chromosomes has important implications for its mode and site of action.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-3417
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
177
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
241-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8551385-Adenocarcinoma,
pubmed-meshheading:8551385-Cell Nucleus,
pubmed-meshheading:8551385-Cytoplasm,
pubmed-meshheading:8551385-Endometrial Hyperplasia,
pubmed-meshheading:8551385-Endometrial Neoplasms,
pubmed-meshheading:8551385-Female,
pubmed-meshheading:8551385-Gene Expression,
pubmed-meshheading:8551385-Humans,
pubmed-meshheading:8551385-Immunoenzyme Techniques,
pubmed-meshheading:8551385-Neoplasm Proteins,
pubmed-meshheading:8551385-Precancerous Conditions,
pubmed-meshheading:8551385-Proto-Oncogene Proteins,
pubmed-meshheading:8551385-Proto-Oncogene Proteins c-bcl-2
|
pubmed:year |
1995
|
pubmed:articleTitle |
Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma.
|
pubmed:affiliation |
Department of Histopathology, Norfolk and Norwich Hospital, U.K.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|